The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats

References

• Moraga P. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. doi:10.1016/s0140-6736(17)32152-9
   PubMed Web of Science ®Google Scholar
• World Health Organization. Mortality and global health estimates. Available from: http://who.int/data/gho/data/themes/mortality-and-global-health-estimates. Accessed November 21, 2020.
   Google Scholar
• Vaughan A, Frazer ZA, Hansbro PM, Yang IA. COPD and the gut-lung axis: the therapeutic potential of fibre. J Thorac Dis. 2019;11(Suppl 17):S2173–S2180. doi:10.21037/jtd.2019.10.40
   PubMed Web of Science ®Google Scholar
• Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15(1):55–63. doi:10.1038/nrmicro.2016.142
   PubMed Web of Science ®Google Scholar
• Bowerman KL, Rehman SF, Vaughan A, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11(1):5886. doi:10.1038/s41467-020-19701-0
   PubMed Web of Science ®Google Scholar
• Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc. 2015;12(Suppl 2):S150–S156. doi:10.1513/AnnalsATS.201503-133AW
   PubMed Web of Science ®Google Scholar
• Hand TW, Vujkovic-Cvijin I, Ridaura VK, Belkaid Y. Linking the microbiota, chronic disease, and the immune system. Trends Endocrinol Metab. 2016;27(12):831–843. doi:10.1016/j.tem.2016.08.003
   PubMed Web of Science ®Google Scholar
• He Y, Wen Q, Yao F, Xu D, Huang Y, Wang J. Gut-lung axis: the microbial contributions and clinical implications. Crit Rev Microbiol. 2017;43(1):81–95. doi:10.1080/1040841X.2016.1176988
   PubMed Web of Science ®Google Scholar
• Macia L, Tan J, Vieira AT, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun. 2015;6(1):6734. doi:10.1038/ncomms7734
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Docampo MD, Riwes M, et al. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 2018;9(1):3674. doi:10.1038/s41467-018-06048-w
   PubMed Web of Science ®Google Scholar
• Hong Y, Li B, Zheng N, et al. Integrated metagenomic and metabolomic analyses of the effect of astragalus polysaccharides on alleviating high-fat diet-induced metabolic disorders. Front Pharmacol. 2020;11:833. doi:10.3389/fphar.2020.00833
   PubMed Web of Science ®Google Scholar
• Zhao P, Li J, Li Y, et al. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:2633–2656. doi:10.2147/COPD.S94043
   PubMed Web of Science ®Google Scholar
• Dong Y, Li Y, Sun Y, et al. Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease. BMC Complement Altern Med. 2015;15(1):51. doi:10.1186/s12906-015-0559-x
   PubMed Web of Science ®Google Scholar
• Li X, Li Y, Mao J, et al. Combination of Chinese and Western medicine optimizes the intestinal microbiota of exacerbated chronic obstructive pulmonary disease in rats. Evid Based Complement Alternat Med. 2021;2021:9975407. doi:10.1155/2021/9975407
   PubMed Web of Science ®Google Scholar
• Zhang XF, Zhu J, Geng WY, et al. Electroacupuncture at Feishu (BL13) and Zusanli (ST36) down-regulates the expression of orexins and their receptors in rats with chronic obstructive pulmonary disease. J Integr Med. 2014;12(5):417–424. doi:10.1016/S2095-4964(14)60040-6
   PubMedGoogle Scholar
• Li Y, Li JS, Li WW, et al. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-kappaB/TGF-beta1/smad2 signaling in rats with chronic obstructive pulmonary disease. BMC Complement Altern Med. 2014;14:140. doi:10.1186/1472-6882-14-140
   PubMed Web of Science ®Google Scholar
• Mao J, Li Y, Feng S, et al. Bufei Jianpi formula improves mitochondrial function and suppresses mitophagy in skeletal muscle via the adenosine monophosphate-activated protein Kinase pathway in chronic obstructive pulmonary disease. Front Pharmacol. 2020;11:587176. doi:10.3389/fphar.2020.587176
   PubMed Web of Science ®Google Scholar
• Huang F, Zheng X, Ma X, et al. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun. 2019;10(1):4971. doi:10.1038/s41467-019-12896-x
   PubMed Web of Science ®Google Scholar
• Tian X, Xue Y, Xie G, et al. (-)-Epicatechin ameliorates cigarette smoke-induced lung inflammation via inhibiting ROS/NLRP3 inflammasome pathway in rats with COPD. Toxicol Appl Pharmacol. 2021;429:115674. doi:10.1016/j.taap.2021.115674
   PubMed Web of Science ®Google Scholar
• Zhang MY, Jiang YX, Yang YC, et al. Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS/NLRP3/caspase-1 pathway. Life Sci. 2021;269:119090. doi:10.1016/j.lfs.2021.119090
   PubMed Web of Science ®Google Scholar
• Zhi ZYZ. Syndrome diagnostic criteria of traditional Chinese medicine for chronic obstructive pulmonary disease; 2011:177–178.
   Google Scholar
• Wang Y, Xu J, Meng Y, et al. Role of inflammatory cells in airway remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3341–3348. doi:10.2147/COPD.S176122
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023. doi:10.1038/sigtrans.2017.23
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhao W. NLRP3 inflammasome-A key player in antiviral responses. Front Immunol. 2020;11:211. doi:10.3389/fimmu.2020.00211
   PubMed Web of Science ®Google Scholar
• Tan JY, Tang YC, Huang J. Gut Microbiota and Lung Injury. Adv Exp Med Biol. 2020;1238:55–72. doi:10.1007/978-981-15-2385-4-5
   PubMed Web of Science ®Google Scholar
• Chunxi L, Haiyue L, Yanxia L, Jianbing P, Jin S. The gut microbiota and respiratory diseases: new evidence. J Immunol Res. 2020;2020:2340670. doi:10.1155/2020/2340670
   PubMed Web of Science ®Google Scholar
• Lee SH, Yun Y, Kim SJ, et al. Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study. J Clin Med. 2018;7(9):282. doi:10.3390/jcm7090282
   PubMed Web of Science ®Google Scholar
• Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One. 2013;8(3):e59260. doi:10.1371/journal.pone.0059260
   PubMed Web of Science ®Google Scholar
• Allais L, Kerckhof FM, Verschuere S, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol. 2016;18(5):1352–1363. doi:10.1111/1462-2920.12934
   PubMed Web of Science ®Google Scholar
• Fernandes J, Su W, Rahat-Rozenbloom S, et al. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes. 2014;4:e121. doi:10.1038/nutd.2014.23
   PubMed Web of Science ®Google Scholar
• Wang Y, Li N, Li Q, et al. Xuanbai Chengqi decoction ameliorates pulmonary inflammation via reshaping gut microbiota and rectifying Th17/Treg imbalance in a murine model of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:3317–3335. doi:10.2147/COPD.S337181
   PubMed Web of Science ®Google Scholar
• Ji J, Ge X, Chen Y, et al. Daphnetin ameliorates experimental colitis by modulating microbiota composition and Treg/Th17 balance. FASEB J. 2019;33(8):9308–9322. doi:10.1096/fj.201802659RR
   PubMed Web of Science ®Google Scholar
• Yang H, Duan Z. The local defender and functional mediator: gut microbiome. Digestion. 2018;97(2):137–145. doi:10.1159/000484687
   PubMed Web of Science ®Google Scholar
• Anand S, Mande SS. Diet, microbiota and gut-lung connection. Front Microbiol. 2018;9:2147. doi:10.3389/fmicb.2018.02147
   PubMed Web of Science ®Google Scholar
• Donovan C, Liu G, Shen S, et al. The role of the microbiome and the NLRP3 inflammasome in the gut and lung. J Leukoc Biol. 2020;108(3):925–935. doi:10.1002/JLB.3MR0720-472RR
   PubMed Web of Science ®Google Scholar
• Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol. 2018;15(12):721–737. doi:10.1038/s41575-018-0054-1
   PubMed Web of Science ®Google Scholar
• Nachmias N, Langier S, Brzezinski RY, et al. NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. PLoS One. 2019;14(5):e0214622. doi:10.1371/journal.pone.0214622
   PubMed Web of Science ®Google Scholar